scanX
Home
Caplin Point Laboratories

Caplin Point Laboratories

1,965.50
-42.35
(-2.11%)
Market Cap (₹ Cr.)
₹15,241
52 Week High
2,158.80
Book Value
₹305
52 Week Low
954.00
PE Ratio
31.91
PB Ratio
7.26
PE for Sector
57.62
PB for Sector
19.92
ROE
19.77 %
ROCE
70.19 %
Dividend Yield
0.25 %
EPS
₹62.84
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
15.65 %
Net Income Growth
22.40 %
Cash Flow Change
17.33 %
ROE
-0.53 %
ROCE
-0.76 %
EBITDA Margin (Avg.)
7.58 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
62
68
76
78
80
81
84
91
98
106
118
113
114
143
138
147
144
160
138
163
133
124
120
127
130
147
179
137
122
151
159
160
157
201
204
151
176
207
Expenses
47
49
55
55
59
59
61
65
63
68
67
74
76
85
89
91
85
82
81
97
62
62
61
66
80
71
89
75
74
70
80
79
80
97
90
70
82
104
EBITDA
15
19
21
23
21
21
23
26
35
38
50
39
38
59
49
57
60
78
57
66
72
62
59
61
51
76
90
62
49
81
80
81
77
104
114
81
94
103
Operating Profit %
20 %
25 %
26 %
27 %
24 %
23 %
26 %
26 %
33 %
33 %
35 %
33 %
32 %
32 %
32 %
35 %
40 %
42 %
39 %
37 %
38 %
48 %
48 %
46 %
35 %
44 %
45 %
42 %
34 %
40 %
42 %
39 %
45 %
44 %
50 %
48 %
41 %
44 %
Depreciation
1
3
2
3
3
3
3
3
5
4
4
5
6
5
6
6
4
4
4
5
6
5
5
6
6
6
6
6
7
6
7
6
6
7
7
7
7
6
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
14
16
19
21
19
19
21
23
30
34
46
35
32
53
43
51
55
74
53
61
66
56
54
55
45
69
83
56
42
75
73
74
71
97
107
74
87
97
Tax
2
4
4
5
1
4
5
5
2
9
12
9
10
9
11
14
19
13
12
15
16
14
13
14
13
15
18
16
13
14
18
17
18
22
27
20
17
25
Net Profit
11
13
14
16
15
14
17
18
22
24
33
24
22
41
30
37
40
60
40
48
50
42
41
41
31
55
65
39
29
63
58
59
54
76
82
55
70
73
EPS in ₹
7.01
8.40
1.88
10.57
10.03
9.44
11.06
2.33
2.89
3.23
4.34
3.12
2.94
5.47
3.95
4.88
5.34
7.95
5.26
6.29
6.63
5.55
5.45
5.48
4.16
7.21
8.61
5.17
3.83
8.34
7.59
7.80
7.15
10.04
10.82
7.30
9.20
9.55
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
223
263
317
411
539
691
861
1,054
1,303
1,522
Fixed Assets
111
143
152
169
138
167
183
162
157
166
Current Assets
77
115
137
213
288
381
513
606
662
703
Capital Work in Progress
31
0
3
15
9
4
1
3
43
28
Investments
0
0
19
48
168
196
149
265
485
584
Other Assets
81
120
143
178
225
325
528
624
619
745
Total Liabilities
130
134
117
115
107
91
102
124
163
132
Current Liabilities
119
121
97
87
83
64
77
99
147
119
Non Current Liabilities
10
14
20
28
25
27
25
25
16
13
Total Equity
94
128
200
296
432
600
759
931
1,140
1,390
Reserve & Surplus
79
113
185
280
417
585
744
915
1,125
1,375
Share Capital
15
15
15
15
15
15
15
15
15
15
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
17
24
12
-49
16
13
287
-68
41
-41
Investing Activities
-24
-6
-37
-60
-76
-41
-4
-276
-86
-118
Operating Activities
50
44
55
23
107
87
295
231
157
111
Financing Activities
-9
-14
-7
-12
-15
-33
-3
-23
-30
-34
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
69.03 %
69.03 %
69.03 %
68.91 %
68.89 %
68.88 %
68.88 %
68.80 %
70.66 %
70.63 %
70.63 %
70.62 %
70.62 %
70.56 %
FIIs
0.68 %
1.15 %
1.76 %
2.11 %
2.07 %
2.03 %
2.15 %
2.24 %
2.36 %
2.67 %
3.07 %
2.83 %
3.32 %
3.36 %
DIIs
1.28 %
1.48 %
1.19 %
1.22 %
1.25 %
1.12 %
1.12 %
1.12 %
0.65 %
0.28 %
0.22 %
0.44 %
1.10 %
1.51 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.01 %
28.34 %
28.02 %
27.76 %
27.78 %
27.97 %
27.85 %
27.84 %
26.34 %
26.42 %
26.08 %
26.10 %
24.95 %
24.57 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,359.60 1,16,815.97 69.82 10,785.75 11.59 1,656 20.90 47.50
Ajanta Pharma
3,121.15 39,351.06 46.09 4,293.31 11.77 816 18.09 49.72
Gland Pharma
1,841.50 30,430.47 42.14 5,834.96 50.97 772 -25.94 37.24
Eris Lifesciences
1,397.05 18,928.93 49.77 2,032.96 19.85 397 -4.52 62.53
Caplin Point Laboratories
1,965.50 15,241.11 31.91 1,761.04 15.65 461 19.85 57.70
Marksans Pharma
281.22 13,424.98 40.20 2,227.83 16.55 315 26.45 67.40
Shilpa Medicare
901.90 8,720.99 212.33 1,159.77 8.64 32 1,091.53 73.96
Jeena Sikho Lifecare
1,406.80 3,353.63 100.45 207.35 40.06 34 - 55.67
Amrutanjan Health Care
804.90 2,253.29 52.91 192.42 12.50 21 -34.09 56.41
Syncom Formulations
23.18 2,241.90 79.50 238.85 3.11 20 73.41 56.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
57.70
ATR(14)
Less Volatile
88.97
STOCH(9,6)
Neutral
31.34
STOCH RSI(14)
Oversold
16.00
MACD(12,26)
Bearish
-12.78
ADX(14)
Very Strong Trend
54.04
UO(9)
Bearish
45.79
ROC(12)
Uptrend But Slowing Down
4.28
WillR(14)
Neutral
-55.47
Bearish
6
Neutral
2
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.